“Soft-tissue management is not an optional add-on; it is an integral component of treatment planning.”
Dr Khoury, what are the primary goals of soft-tissue management today, and how does it influence clinical outcomes in relation to peri-implant health, aesthetics, patient comfort and long-term stability?
Implant dentistry has reached a high level of technical maturity in recent years. However, long-term success is strongly influenced by the quality and quantity of the peri-implant soft tissue. Beyond purely functional considerations, stability, cleansability and aesthetics have become key priorities. Therefore, soft-tissue management is not an optional add-on; it is an integral component of treatment planning before, during and after augmentation and implant placement.
In the pre-augmentation planning phase, how does your evaluation of the soft tissue influence the overall treatment plan and timing, and which soft-tissue augmentation procedures do you consider standard at this stage?
Within a pre-augmentation treatment concept, the primary focus is initially on rebuilding hard-tissue structures. However, establishing stable, well-vascularised soft-tissue conditions is a decisive prerequisite for successful bone augmentation. Free connective tissue grafts are a commonly used form of soft-tissue augmentation in this context, as they can be used in both the maxilla and mandible and provide reliable increases in peri-implant soft-tissue volume.
A pedicled palatal flap harvested from the palate for soft-tissue augmentation.
In severely compromised recipient sites, the advantages of a pedicled palatal connective tissue flap can be used. Because the graft remains pedicled to the palate, its vascularity is preserved, which can support improved integration and reduce postoperative shrinkage. When combined with augmentation procedures, this approach enables double-layer wound closure that helps protect the bony graft from dehiscence, exposure and infection. At the same time, it thickens the peri-implant soft tissue—an important benefit, particularly in the aesthetically critical maxillary anterior region. However, this technique is anatomically limited to the maxilla. As an adjunct, minimally invasive option, the soft-tissue punch technique may be used, especially after tooth extraction, to protect the blood clot and stabilise early soft-tissue healing.
What options are available for targeted soft-tissue management during implant placement and bone augmentation?
During implant placement and bone augmentation, incision design, flap mobilisation and suture positioning are critical for achieving tension-free wound closure. Tunnel and lateral tunnel techniques allow the suture line to be kept away from the augmented area, thereby reducing the risk of dehiscence.
A key challenge, particularly in the mandible, is the frequent lack of keratinised mucosa. In this setting, Kazanjian vestibuloplasty enables reconstruction of the vestibule and creation of keratinised, attached mucosa in a single-stage approach performed simultaneously with implant placement and augmentation. By selectively repositioning the muscle attachment and relocating the mucosa, a functionally stable, cleansable soft-tissue environment can be achieved.
As a more specialised refinement, the masseter-buccinator periosteal flap can be used in the posterior mandible. By providing double-layer wound closure, it may offer advantages in compromised recipient sites and reduce the risk of exposure of the augmented bone.
“Proactive soft-tissue management will become an increasingly important hallmark of high-quality implant care.”
Which methods are suitable for soft-tissue management after implant placement?
After implant placement, the focus shifts to long-term stabilisation of the peri-implant tissues. Free mucosal grafts remain an established option for increasing the width of keratinised and attached mucosa. As an adjunct, apically positioned flaps—either alone or combined with connective tissue grafts—can be used to transpose keratinised mucosa vestibularly. Roll-flap techniques are particularly useful in the maxilla for horizontal soft-tissue volume gain and optimisation of the emergence profile. In the aesthetic zone, papilla reconstruction may be required; these measures are planned on an individual basis depending on defect morphology and the available soft-tissue volume.
Looking ahead, what developments do you expect to most influence implant dentistry, and what evidence or clinical needs are driving that change?
Modern implant dentistry is moving towards a biologically driven, comprehensive treatment concept. The clinical need is clear: long-term therapeutic success depends to a large extent on healthy, stable and cleansable peri-implant soft tissue. Therefore, proactive soft-tissue management will therefore become an increasingly important hallmark of high-quality implant care.
